Platelet-rich Plasma Modulates the Secretion of Inflammatory/Angiogenic Proteins by Inflamed Tenocytes
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Platelet-rich plasma therapies for tendinopathy appear to provide moderate pain reduction. However, the biological mechanisms behind the observed clinical effects remain poorly characterized. QUESTIONS/PURPOSES: The purpose of this study was to explore whether platelet-rich plasma modifies the inflammatory/angiogenic status of already inflamed tenocytes by examining (1) gene expression; (2) modulation of chemokine and interleukin secretion; and (3) differences between healthy and tendinopathic tenocytes. METHODS: Cells from both healthy and tendinopathic tendons were exposed to interleukin (IL)-1ß and after treated with platelet-rich plasma. Modifications in the expression of selected genes were assessed by real-time reverse transcription-polymerase chain reaction and changes in secretion of angiogenic/inflammatory molecules by enzyme-linked immunosorbent assay. Platelet-rich plasma-induced changes in tendinopathic cells were compared with normal after normalizing platelet-rich plasma data against IL-1ß status in each specific sample. RESULTS: In IL-1ß-exposed cells, platelet-rich plasma downregulates expression of IL-6/CXCL-6 (mean, 0.015; 95% confidence interval [CI], 0.005-0.025; p = 0.026), IL-6R (mean, 0.61; 95% CI, 0.27-0.95; p = 0.029), and IL-8/CXCL-8 (mean, 0.02; 95% CI, 0.007-0.023; p = 0.026). Secretion of IL-6/CXCL6, 0.35 (95% CI, 0.3-0.4; p = 0.002), IL-8/CXCL8, 0.55 (95% CI, 0.5-0.7; p = 0.01), and monocyte chemoattractant protein-1/CCL2, 0.40 (95% CI, 0.2-0.6; p = 0.001) was reduced by platelet-rich plasma, whereas vascular endothelial growth factor increased by twofold, (95% CI, 1.7-2.3; p < 0.001). RANTES/CCL5 increased by10-fold (95% CI, 4-17) and hepatocyte growth factor by 21-fold (95% CI, 0.2-42) in tendinopathic and by 2.3-fold (95% CI, 2-3) and threefold (95% CI, 1-5) in normal cells (p = 0.005 for both). CONCLUSIONS: Platelet-rich plasma induces an immunomodulatory and proangiogenic phenotype consistent with healing mechanisms with few differences between tendinopathic and normal cells. CLINICAL RELEVANCE: Platelet-rich plasma injections in pathological and nearby tissue might help to recover tendon homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anitua, E., Sanchez, M., Nurden, A. T., Zalduendo, M., de la Fuente, M., Orive, G., Azofra, J., & Andia, I. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30585 · Cited by 188 · cited 1×
“Understanding their mechanisms of action will allow us to extend previous knowledge reporting on MCP-1/CCL2, RANTES/CCL5, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) production by tendon cells after PRP treatment [11, 12].”
The Influence of Platelet-Rich Plasma on Angiogenesis During the Early Phase of Tendon Healing
Lyras, D. N., Kazakos, K., Verettas, D., Polychronidis, A., Tryfonidis, M., Botaitis, S., Agrogiannis, G., Simopoulos, C., Kokka, A., & Patsouris, E. (2009) · Foot & Ankle International · doi:10.3113/fai.2009.1101 · Cited by 147 · cited 1×
“The multimolecular preparations, obtained from autologous blood, provide clinical benefits by modulating the early healing response through secretion of an array of signaling cytokines that influence inflammation and angiogenesis concurrently and influence cell migration and proliferation [10, 13, 23, 24].”
Cited by
Therapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,021
Inflammatory mechanisms in tendinopathy – towards translation
Millar, N. L., Murrell, G. A. C., & McInnes, I. B. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.213 · Cited by 404
Chen, X., Jones, I. A., Park, C., & Vangsness, C. T. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517743746 · Cited by 294
Yan, R., Gu, Y., Ran, J., Hu, Y., Zheng, Z., Zeng, M., Heng, B. C., Chen, X., Yin, Z., Chen, W., et al. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517694357 · Cited by 124
“A previous study reported that Lp-PRP reduced the secretion of IL-6 by inflamed tenocytes.(3) In another study, it was observed that platelets can interact with leukocytes to trigger the release of proinflammatory cytokines such as IL-6 in vitro.”
BackgroundScaffold-Mediated Immunoengineering as Innovative Strategy for Tendon Regeneration
Russo, V., El Khatib, M., Prencipe, G., Cerveró-Varona, A., Citeroni, M. R., Mauro, A., Berardinelli, P., Faydaver, M., Haidar-Montes, A. A., Turriani, M., et al. (2022) · Cells · doi:10.3390/cells11020266 · Cited by 49
Metadata
- Authors
- Andia, I., Rubio-Azpeitia, E., & Maffulli, N.
- Venue
- Clinical Orthopaedics & Related Research
- Published
- 2015-05
- Volume
- 473
- Issue
- 5
- Pages
- 1624-1634
- ISSN
- 0009-921X (ISSN-L)
- OpenAlex
- W2067364805
- Cited by
- 96
- References
- 2
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet-rich Plasma Modulates the Secretion of Inflammatory/Angiogenic Proteins by Inflamed Tenocytes. https://app.cochat.ai/papers/10.1007/s11999-015-4179-z
- The paper
- Andia, I., Rubio-Azpeitia, E., & Maffulli, N. (2015). Platelet-rich Plasma Modulates the Secretion of Inflammatory/Angiogenic Proteins by Inflamed Tenocytes. Clinical Orthopaedics & Related Research. https://doi.org/10.1007/s11999-015-4179-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.